Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma

Nanotechnology

Volumn 18, Issue 38, 2007, Pages

  McNeeley, Kathleen M ^a   Annapragada, Ananth ^b   Bellamkonda, Ravi V ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b University of Texas School of Health Information Sciences at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BRAIN; DRUG DELIVERY; MATHEMATICAL MODELS; POLYETHYLENE GLYCOLS; TUMORS;

CIRCULATION TIME; EXTRAVASATION; LIPOSOMAL NANOCARRIERS; PASSIVE ACCUMULATION;

ONCOLOGY;

DOXORUBICIN; FOLATE RECEPTOR; NANOCARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCULATION; CONTROLLED STUDY; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; GENE TARGETING; GLIOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

EID: 34848883058     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/18/38/385101     Document Type: Article

References (76)

1. Blume G and Cevc G 1990 Liposomes for the sustained drug release in vivo Biochim. Biophys. Acta 1029 91-7
2. Klibanov a L, Maruyama K, Torchilin V P and Huang L 1990 Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 235-7
3. Maruyama K, Yuda T, Okamoto A, Ishikura C, Kojima S and Iwatsuru M 1991 Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes Chem. Pharm. Bull. (Tokyo) 39 1620-2
4. Allen T M, Hansen C, Martin F, Redemann C and Yau-Young A 1991 Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 29-36
5. Harris J M, Martin N E and Modi M 2001 Pegylation: a novel process for modifying pharmacokinetics Clin. Pharmacokinet. 40 539-51
6. Allen C et al 2002 Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) Biosci. Rep. 22 225-50
7. Moghimi S and Szebeni J 2003 Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 463-78
8. Hong R L, Huang C J, Tseng Y L, Pang V F, Chen S T, Liu J J and Chang F H 1999 Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 5 3645-52
9. Duncan R 1999 Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. Technol. Today 11 441-9
10. Maeda H, Wu J, Sawa T, Matsumura Y and Hori K 2000 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control. Release 65 271-84
11. Takeuchi H, Kojima H, Yamamoto H and Kawashima Y 2001 Passive targeting of doxorubicin with polymer coated liposomes in tumor bearing rats Biol. Pharm. Bull. 24 795-99
12. Maeda H 2001 The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 189-207
13. Ishida O, Maruyama K, Sasaki K and Iwatsuru M 1999 Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice Int. J. Pharm. 190 49-56
14. Litzinger D C, Buiting A M, Van Rooijen N and Huang L 1994 Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes Biochim. Biophys. Acta 1190 99-107
15. Mayer L D, Tai L C, Ko D S, Masin D, Ginsberg R S, Cullis P R and Bally M B 1989 Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice Cancer Res. 49 5922-30
16. Campbell R B, Fukumura D, Brown E B, Mazzola L M, Izumi Y, Jain R K, Torchilin V P and Munn L L 2002 Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors Cancer Res. 62 6831-6
17. Simoes S, Moreira J, Fonseca C, Duzgunes N and De Lima M 2004 On the formulation of pH-sensitive liposomes with long circulation times Adv. Drug Deliv. Rev. 56 947-65
18. Maruyama K, Kennel S and Huang L 1990 Lipid composition is important for highly efficient target binding and retention of immunoliposomes Proc. Natl Acad. Sci. USA 87 5744-8
19. Patel H, Tuzel N and Ryman B 1983 Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen Biochim. Biophys. Acta 761 142-51
20. Woodle M C and Lasic D D 1992 Sterically stabilized liposomes Biochim. Biophys. Acta 1113 171-99
21. Minko T, Pakunlu R, Wang Y, Khandare J and Saad M 2006 New generation of liposomal drugs for cancer Anticancer Agents Med. Chem. 6 537-52
22. Gutman R L, Peacock G and Lu D R 2000 Targeted drug delivery for brain cancer treatment J Control. Release 65 31-41
23. Torchilin V P 2000 Drug targeting Eur. J. Pharm. Sci. 11 (Suppl. 2) S81-91
24. Lestini B J et al 2002 Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery J. Control Release 78 235-47
25. Klibanov a L 1998 Antibody-mediated targeting of PEG coated liposomes Long Circulating Liposomes: Old Drugs, New Therapeutics ed M Woodle and G Storm pp 269-86
26. Maruyama K, Ishida O, Takizawa T and Moribe K 1999 Possibility of active targeting to tumor tissues with liposomes Adv. Drug Deliv. Rev. 40 89-102
27. Blume G, Cevc G, Crommelin M D, Bakker-Woudenberg I A, Kluft C and Storm G 1993 Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times Biochim. Biophys. Acta 1149 180-4
28. Allen T M, Brandeis E, Hansen C B, Kao G Y and Zalipsky S 1995 A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells Biochim. Biophys. Acta 1237 99-108
29. Allen T M, Brandeis E, Hansen C B, Kao G Y and Zalipsky S 1995 Biochim. Biophys. Acta 1240 285 (erratum)
30. Saul J M, Annapragada A, Natarajan J V and Bellamkonda R V 2003 Controlled targeting of liposomal doxorubicin via the folate receptor in vitro J Control. Release 92 49-67
31. Saul J M, Annapragada a V and Bellamkonda R V 2006 A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers J Control. Release 114 277-87
32. Lee R J and Low P S 1995 Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro Biochim. Biophys. Acta 1233 134-44
33. Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M and Yanagie H 2001 Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 1042-8
34. Eavarone D A, Yu X and Bellamkonda R V 2000 Targeted drug delivery to C6 glioma by transferrin-coupled liposomes J. Biomed. Mater. Res. 51 10-4
35. Pastorino F et al 2003 Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy Cancer Res. 63 7400-9
36. Moreira J N, Ishida T, Gaspar R and Allen T M 2002 Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity Pharm. Res. 19 265-9
37. Park J W, Hong K, Kirpotin D B, Meyer O, Papahadjopoulos D and Benz C C 1997 Anti-HER2 immunoliposomes for targeted therapy of human tumors Cancer Lett. 118 153-60
38. Park J W et al 2002 Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery Clin. Cancer Res. 8 1172-81
39. Maruyama K, Takizawa T, Yuda T, Kennel S J, Huang L and Iwatsuru M 1995 Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies Biochim. Biophys. Acta 1234 74-80
40. Gabizon A, Horowitz a T, Goren D, Tzemach D, Shmeeda H and Zalipsky S 2003 In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice Clin. Cancer Res. 9 6551-9
41. Leamon C P, Cooper S R and Hardee G E 2003 Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo Bioconjug. Chem. 14 738-47
42. Shmeeda H, Mak L, Tzemach D, Astrahan P, Tarshish M and Gabizon A 2006 Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors Mol. Cancer Ther. 5 818-24
43. Reddy J A, Abburi C, Hofland H, Howard S J, Vlahov I, Wils P and Leamon C P 2002 Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors Gene Ther. 9 1542-50
44. Pan X Q and Lee R J 2005 In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model Anticancer Res. 25 343-6
45. Turk M J, Waters D J and Low P S 2004 Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma Cancer Lett. 213 165-72
46. Yuan F, Leunig M, Huang S K, Berk D A, Papahadjopoulos D and Jain R K 1994 Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft Cancer Res. 54 3352-6
47. Pan X Q, Hang H and Lee R J 2003 Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model Pharm. Res. 20 417-22
48. Goren D, Horowitz a T, Tzemach D, Tarshish M, Zalipsky S and Gabizon A 2000 Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump Clin. Cancer Res. 6 1949-57
49. Gabizon A, Shmeeda H, Horowitz a T and Zalipsky S 2004 Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates Adv. Drug Deliv. Rev. 56 1177-92
50. Wu J, Liu Q and Lee R J 2006 A folate receptor-targeted liposomal formulation for paclitaxel Int. J. Pharm. 316 148-53
51. Huwyler J, Wu D and Pardridge W M 1996 Brain drug delivery of small molecules using immunoliposomes Proc. Natl Acad. Sci. USA 93 14164-9
52. Walker M D et al 1980 Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N. Engl. J. Med. 303 1323-9
53. Walker M D et al 1978 Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas.A cooperative clinical trial J. Neurosurg. 49 333-43
54. Hatlevoll R et al 1985 Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group Cancer 56 41-7
55. Trojanowski T et al 1988 Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas J. Neurooncol. 6 285-91
56. Wolff J E, Trilling T, Molenkamp G, Egeler R M and Jurgens H 1999 Chemosensitivity of glioma cells in vitro:a meta analysis J. Cancer Res. Clin. Oncol. 125 481-6
57. Chua S L, Rosenthal M A, Wong S S, Ashley D M, Woods a M, Dowling A and Cher L M 2004 Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme Neurooncology 6 38-43
58. Hau P et al 2004 Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma Cancer 100 1199-207
59. Steiniger S et al 2004 Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles Int. J. Cancer 109 759-67
60. Ghaghada K B, Saul J, Natarajan J V, Bellamkonda R V and Annapragada a V 2005 Folate targeting of drug carriers: a mathematical model J Control. Release 104 113-28
61. Sudimack J and Lee R J 2000 Targeted drug delivery via the folate receptor Adv. Drug Deliv. Rev. 41 147-62
62. Sudimack J J, Adams D, Rotaru J, Shukla S, Yan J, Sekido M, Barth R F, Tjarks W and Lee R J 2002 Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy Pharm. Res. 19 1502-8
63. Gabizon A, Horowitz a T, Goren D, Tzemach D, Mandelbaum-Shavit F, Qazen M M and Zalipsky S 1999 Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies Bioconjug. Chem. 10 289-98
64. Lasic D 1993 Preparation of liposomes Liposomes: From Physics to Applications ed D Lasic (New York: Elsevier) pp 63-107
65. Bolotin E M, Cohen R, Bar L K, Emanuel N, Ninio S, Lasic D D and Barenholz Y 1994 Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes J. Liposome Res. 4 455-79
66. Zalipsky S, Brandeis E, Newman M S and Woodle M C 1994 Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine FEBS Lett. 353 71-4
67. Ishida T, Iden D L and Allen T M 1999 A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs FEBS Lett. 460 129-33
68. Siegal T, Horowitz A and Gabizon A 1995 Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy J. Neurosurg. 83 1029-37
69. Kirpotin D B, Drummond D C, Shao Y, Shalaby M R, Hong K, Nielsen U B, Marks J D, Benz C C and Park J W 2006 Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 6732-40
70. Charrois G J and Allen T M 2004 Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer Biochim. Biophys. Acta 1663 167-77
71. Gabizon A, Tzemach D, Mak L, Bronstein M and Horowitz A 2002 Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models J. Drug Target. 10 539-48
72. Lee R J and Low P S 1994 Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis J. Biol. Chem. 269 3198-204
73. Arnold R D, Mager D E, Slack J E and Straubinger R M 2005 Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model Clin. Cancer Res. 11 8856-65
74. Schiffelers R M, Bakker-Woudenberg I A and Storm G 2000 Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly(ethylene)glycol coating Biochim. Biophys. Acta 1468 253-61
75. Weissleder R, Cheng H C, Marecos E, Kwong K and Bogdanov A Jr 1998 Non-invasive in vivo mapping of tumour vascular and interstitial volume fractions Eur. J. Cancer 34 1448-54
76. Gabizon A and Papahadjopoulos D 1988 Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Proc. Natl Acad. Sci. USA 85 6949-53